Exploratory research conducted at St. Peter’s Hospital in conjunction with New York Oncology Hematology, is featured in the national medical journal, Science Immunology. The research involves the cancer drug Acalabrutinib and its potential as a possible treatment for COVID-19. […]
The Times Union did a story about how SPHP is among the first hospital systems nationwide to receive federal approval for an experimental COVID-19 treatment. […]
Multiple groundbreaking therapies to treat the sickest COVID-positive patients in the Capital Region are being employed at St. Peter’s Health Partners’ (SPHP) acute care hospitals in Albany and Troy. They include the antiviral drug remdesivir; IL-6 inhibitor drugs; macrophage inhibitors; and convalescent blood plasma therapy. […]
Results demonstrated that tailored light therapy significantly improved sleep, and reduced depression and agitation in memory loss patients. […]
The Times Union published commentary on the safety of e-cigarettes written by Theresa Zubretsky, community engagement coordinator with Capital District Tobacco-Free Communities. […]
Written by Paul Novak, program director of the Neuro-Rehabilitation Institute at Sunnyview Rehabilitation Hospital, this article recognizes Brain Injury Awareness Month and discusses different types of brain injuries and how they can change a person’s life forever. […]
The Lustgarten Foundation’s 14th Annual Albany Capital District Walk for Pancreatic Cancer Research will be held at 10:15 a.m. on Sunday, September 10th, at Elm Town Park in Delmar. […]
© 2024 St. Peter's Health Partners. All rights reserved.
315 S. Manning Blvd., Albany, NY 12208, 518-525-1111